Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
New Podcast CE Alert: "Meds for Alzheimer Dementia" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
  1. Home
  2. Browse
  3. Cardiology
  4. Ischemic Heart Disease/Acute Coronary Syndromes
  5. Treatment
  6. Anticoagulants

Anticoagulants

  • Angina (20)
  • Antithrombotics (437)
  • Arrhythmias (189)
  • Blood Pressure (38)
  • Cardiovascular Disease and Depression (10)
  • Cholesterol (102)
  • Dyslipidemia (328)
  • Endocarditis (22)
  • Heart Disease (105)
  • Heart Failure (234)
  • Hypertension (372)
  • Hypotension (24)
  • Ischemic Heart Disease/Acute Coronary Syndromes (417)
    • Cardiovascular Markers (37)
    • Drug-Induced Ischemic Heart Disease (43)
    • Guidelines (4)
    • Prevention (97)
    • Treatment (316)
      • ACEIs (67)
      • Anticoagulants (39)
      • ARBs (62)
      • ARNIs (8)
      • Aspirin (94)
      • Beta-Blockers (85)
      • Calcium Channel Blockers (28)
      • Cangrelor (Kengreal) (2)
      • Clopidogrel (Plavix) (57)
      • Natural Medicines/Supplements (7)
      • Nitrates (20)
      • Prasugrel (Effient) (31)
      • Statins (59)
  • Myocardial Infarction (56)
  • Peripheral Vascular Disease (9)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (3)
  • Resources (1090)
  • Stroke (202)
16 - 30 of 39 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Commentary: Oral Anticoagulants: Maximizing Safety October 2015
Chart: Antimicrobial Drug Interactions and Warfarin August 2014
PL Voices: Adherence with the New Oral Anticoagulants July 2013
Article: boxed warning about stopping Pradaxa (dabigatran), Xarelto (rivaroxaban), or Eliquis (apixaban) in atrial fib patients July 2013
Patient Education: Why It’s Important to Take Your Blood Thinning Meds June 2013
Other: Warfarin Dose Calculator June 2012
Commentary: Antiplatelets After Acute Coronary Syndrome or Coronary Stent May 2012
PL Voices: Which Antiplatelet Drug to Add to Aspirin for Acute Coronary Syndrome May 2012
Article: Brilinta (ticagrelor) for acute coronary syndrome May 2012
Article: more emphasis on preventing bleeding due to anticoagulants in elderly patients January 2012
Article: how to reverse bleeding due to Pradaxa or Xarelto September 2011
Article: whether dosage changes are needed for the new, LOWER potency unfractionated heparin November 2009
Commentary: Change in Heparin Potency November 2009
Guideline: Primary and Secondary Prevention of Coronary Artery Disease (ACCP, 8th edition) September 2009
Guideline: Percutaneous Coronary Intervention (ACC/AHA/SCAI, 2007 Update) September 2009
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved